Searching:
Search by keyword, patent number, inventor, assignee, city or state:
| Patent # | Description |
|---|---|
| 2011/0243918 |
TOPICAL MEDICATION FOR THE TREATMENT OF HEMORRHOIDS AND METHOD OF USE A natural gel/ointment for the treatment of hemorrhoids. Bromelain is one primary active ingredient in the gel/ointment. A second active ingredient such as... |
| 2011/0243917 |
COMPOSITION FOR THE PREVENTION AND TREATMENT OF ABSENCE SEIZURES
COMPRISING PKC AGONIST AS AN EFFECTIVE INGREDIENT The present invention relates to a composition comprising PKC agonist as an active ingredient. More precisely, the present inventors confirmed that absence... |
| 2011/0243916 |
MODIFIED ENDOLYSIN PLY511 The present invention relates to polypeptides with a changed amino acid sequence on at least one amino acid position compared to the amino acid sequence... |
| 2011/0243915 |
ANTIMICROBIAL AGENTS The present invention relates to endolysin variants comprising an endolysin to which a peptide stretch with membrane or LPS disrupting activity is fused.... |
| 2011/0243914 |
SHIGA TOXIN B-SUBUNIT AS A VECTOR FOR TUMOR DIAGNOSIS AND DRUG DELIVERY TO
GB3 EXPRESSING TUMORS The invention relates to new compounds for cancer therapy or diagnosis and more specifically to the use of a non-toxic B subunit of Shiga toxin mutant as a... |
| 2011/0243913 |
Biomaterial Compositions and Methods of Use The invention relates to biomaterial compositions and methods for promoting bone regeneration and hemostasis. The invention also relates to compositions and... |
| 2011/0243912 |
Growth Factor Binding Constructs Materials and Methods The present invention provides materials and methods for antagonizing the function of vascular endothelial growth factor receptors, platelet derived growth... |
| 2011/0243911 |
USE OF A COMPOUND CAPABLE OF REDUCING THE URIC ACID LEVEL FOR THE
PREVENTION AND/OR THE TREATMENT OF LUNG... The present invention is directed to the use of a compound capable of reducing the uric acid level in a mammal for the prevention and/or the treatment of... |
| 2011/0243910 |
MAMMALIAN RNA DEPENDENT RNA POLYMERASE The invention provides compositions comprising a TERT-RMRP or TERT-RNA complex and methods of treating subjects with genetic diseases in which gene silencing is... |
| 2011/0243909 |
Compositions and Methods for Treating Collagen-Mediated Diseases A drug product comprising a combination of highly purified collagenase I and collagenase II from Colostridium histolyticum is disclosed. The drug product... |
| 2011/0243908 |
Compositions and Methods for Treating Collagen-Mediated Diseases A drug product comprising a combination of highly purified collagenase I and collagenase II from Colostridium histolyticum is disclosed. The drug product... |
| 2011/0243907 |
COSMETIC AND NUTRITIONAL ALPHA-OMEGA COMPLEX COMPOSITION The present invention is an alpha omega complex composition for use in cosmetic and nutritional products and formulations for a user that contains coenzyme Q10,... |
| 2011/0243906 |
STRAIN OF HIGHLY MOSQUITOCIDAL BACILLUS A new strain of Bacillus and a method and composition for controlling mosquitoes with the strain. |
| 2011/0243905 |
STRAIN OF HIGHLY MOSQUITOCIDAL BACILLUS A new strain of Bacillus and a method and composition for controlling mosquitoes with the strain. |
| 2011/0243904 |
RNA INTERFERENCE TARGET FOR TREATING AIDS The present invention relates to RNA interference target sequence targeting HIV for the treatment of AIDS. Based on the target sequence, recombinant expression... |
| 2011/0243903 |
USE OF A ROCK INHIBITOR TO SUSTAIN PRIMARY HUMAN KERATINOCYTES IN A
PROLIFERATIVE STATE Disclosed herein is the finding that treatment with a ROCK inhibitor increases proliferation and induces immortalization of primary keratinocytes. Accordingly,... |
| 2011/0243902 |
METHOD FOR TREATING OR PREVENTING A PANCREATIC DYSFUNCTION The present invention provides a method for improving pancreatic function in a subject in need thereof, the method comprising administering to the subject... |
| 2011/0243901 |
Compositions and Methods for the Treatment of Lysosomal Storage Disorders The present invention relates to methods for providing lysosomal enzymes to a subject by administering stem cells, preferably Multipotent Adult Progenitor Cells... |
| 2011/0243900 |
SOFT TISSUE AND BONE AUGMENTATION AND BULKING UTILIZING MUSCLE-DERIVED
PROGENITOR CELLS, COMPOSITIONS AND... The present invention provides muscle-derived progenitor cells that show long-term survival following transplantation into body tissues and which can augment... |
| 2011/0243899 |
Wnt Signaling Inhibitor Comprising Insulin-Like Growth Factor-Binding
Protein Provided is a novel soluble factor that modulates morphogenesis and cell proliferation, such as cardiac development and/or cardiomyocyte differentiation.... |
| 2011/0243898 |
SOMATIC CELL-DERIVED PLURIPOTENT CELLS AND METHODS OF USE THEREFOR Provided are methods for producing a reprogrammed fibroblast. The methods can include growing a plurality of fibroblasts in monolayer culture to confluency; and... |
| 2011/0243897 |
MODIFICATION OF NUCLEIC ACID VECTORS WITH POLYMERS COMPRISING CHARGED
QUATERNARY AMINO GROUPS The present invention provides a polymer modified nucleic acid vector in which the nucleic acid vector is covalently linked to a polymer, which polymer... |
| 2011/0243896 |
ANTI-VIRAL PROTECTION WITH VIRUSES CONTAINING DEFECTIVE GENOME SEGMENTS The invention relates to virology and the prevention and/or treatment of viral infection and disease in animals, including birds and humans. The invention... |
| 2011/0243895 |
Generation of patient-specific differentiated cell types by epigenetic
induction Disclosure of a mammalian cytoplasmic donor cell line. Disclosure of a patient specific cell line. Methods to obtain a mammalian cytoplasmic donor cell line by... |
| 2011/0243894 |
METHODS OF TREATING HEPATITIS C VIRUS INFECTION The present invention provides methods of treating hepatitis C virus (HCV) infection; methods of reducing the incidence of complications associated with HCV and... |
| 2011/0243893 |
MARKERS FOR DETERMINATION OF PATIENT RESPONSIVENESS Compositions and methods are provided for prognostic classification of inflammatory diseases, e.g. inflammatory demyelinating disease, patients into subtypes,... |
| 2011/0243892 |
Y-SHAPE BRANCHED HYDROPHILIC POLYMER DERIVATIVES, THEIR PREPARATION
METHODS, CONJUGATES OF THE DERIVATIVES AND... The present invention relates to Y-shape branched PEG derivatives of formulae (I) to (IV). The present invention also relates to conjugates of these Y-shape... |
| 2011/0243891 |
DIHYDROPYRAZOLOPYRIMIDINONE DERIVATIVE The present invention relates to a compound of General Formula (I) below, among others. In the Formula, Ar.sup.1 is an optionally substituted aryl or heteroaryl... |
| 2011/0243890 |
Sensitization of Chemotherapeutic Agent Resistant Neoplastic Cells With a
Virus The present invention relates to a method of increasing the sensitivity of neoplastic cells to chemotherapeutic agents by using a virus, a method of treating... |
| 2011/0243889 |
OPIOID AND OPIOID-LIKE COMPOUNDS AND USES THEREOF The present invention relates to opioid and opioid-like compounds, and pharmaceutical formulations containing the same and methods of use thereof. Uses of the... |
| 2011/0243888 |
IL-29 MUTANTS AND USES THEREOF The present invention relates to truncated IL-29 mutant molecules and methods of using same. The truncated IL-29 molecules can be used to treat viral... |
| 2011/0243887 |
IL-7 FUSION PROTEINS The invention is directed to a fusion protein which includes a first portion including an immunoglobulin (Ig) chain and a second portion including interleukin-7... |
| 2011/0243886 |
COMPOUNDS AND PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OF VIRAL
INFECTIONS Provided herein are compounds, compositions and methods for the treatment of liver disorders, including HCV infections. In one embodiment, compounds and... |
| 2011/0243885 |
Use of Genomic Testing and Ketogenic Compounds for Treatment of Reduced
Cognitive Function This invention relates to methods of using genotyping to select patients for treatment with compounds capable of elevating ketone body concentrations in amounts... |
| 2011/0243884 |
BIODEGRADABLE POLYMER - BIOACTIVE MOIETY CONJUGATES The invention relates to a biodegradable polymer comprising a plurality of releasable bioactive moieties, the releasable bioactive moieties being pendant from... |
| 2011/0243883 |
POLYMERIC BIOLUBRICANTS FOR MEDICAL USE The present invention provides branched polymers which can be used as lubricants or shock absorbers in vivo. For example, the inventive polymers can be used as... |
| 2011/0243882 |
ANTIBACTERIAL POLYMER EMULSION AND COATING COMPOSITION An aqueous antibacterial polymer emulsion and coating compositions are provided. The aqueous antibacterial polymer emulsion comprising a polymer A, an oxidant... |
| 2011/0243881 |
BIOCOMPATIBLE POLYMERS, PROCESS FOR THEIR PREPARATION AND COMPOSITIONS
CONTAINING THEM A process for treating fibroses including administering a therapeutically effective amount of a pharmaceutical composition which includes at least one... |
| 2011/0243880 |
MODIFIED POLYMERS FOR DELIVERY OF POLYNUCLEOTIDES, METHOD OF MANUFACTURE,
AND METHODS OF USE THEREOF A polynucleotide delivery vehicle comprising a modified polymer is provided herein, the modified polymer having the following formula: ##STR00001## in which... |
| 2011/0243879 |
METHODS OF TREATING HEPATIC ENCEPHALOPATHY The application describes treatment of hepatic encephalopathy using gastrointestinal specific antibiotics. One example of a gastrointestinal specific antibiotic... |
| 2011/0243878 |
ORGANOSILICONES The present application relates to organosilicones and compositions such as consumer products comprising such organosilicones, as well as processes for making... |
| 2011/0243877 |
Embalming composition and method A method of retarding the decomposition of human remains comprises embalming the remains with an aqueous solution of chlorine dioxide. |
| 2011/0243876 |
ORGANOSILICONES The present application relates to organosilicones and compositions such as consumer products comprising such organosilicones, as well as processes for making... |
| 2011/0243875 |
CARE POLYMERS The present application relates to care agents, for example care polymers, and compositions such as consumer products comprising such care agents, as well as... |
| 2011/0243874 |
CARE POLYMERS The present application relates to care agents, for example care polymers, and compositions such as consumer products comprising such care agents, as well as... |
| 2011/0243873 |
Rheology modifier polymer A polymer includes (a) one or more first monomeric units, each independently comprising at least one bicycloheptyl-polyether, bicycloheptenyl-polyether or... |
| 2011/0243872 |
CARBOHYDRATE TREATMENT FOR FRAGRANCED ARTICLES A carbohydrate treatment composition composing modified starches, preservatives, an incorporation factor and water The treatment composition may also preferably... |
| 2011/0243871 |
ORGANOSILICONES The present application relates to organosilicones and compositions such as consumer products comprising such organosilicones, as well as processes for making... |
| 2011/0243870 |
CONDITIONING SHAMPOO COMPRISING AN AQEUOUS CONDITIONING GEL PHASE IN THE
FORM OF VESICLES Conditioning shampoo composition comprising a cleaning phase and an aqueous conditioning gel phase comprising a cationic surfactant having from 16 to 30 carbons... |
| 2011/0243869 |
WAX-FREE COSMETIC COMPOSITIONS CONTAINING A LATEX AND A FILLER Disclosed are cosmetic compositions containing from about 10% to about 60% of a latex, and from about 10% to about 60% of a filler; wherein the ratio of latex... |
Copyright 2008−2013 Patents.com
